Cargando…
Precious Gene: The Application of RET-Altered Inhibitors
The well-known proto-oncogene rearrangement during transfection (RET), also known as ret proto-oncogene Homo sapiens (human), is a rare gene that is involved in the physiological development of some organ systems and can activate various cancers, such as non-small cell lung cancer, thyroid cancer, a...
Autores principales: | Gou, Qitao, Gan, Xiaochuan, Li, Longhao, Gou, Qiheng, Zhang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784389/ https://www.ncbi.nlm.nih.gov/pubmed/36557971 http://dx.doi.org/10.3390/molecules27248839 |
Ejemplares similares
-
RET kinase inhibitors for RET-altered thyroid cancers
por: Vodopivec, Danica M., et al.
Publicado: (2022) -
Dynamic change of the systemic immune inflammation index is a risk factor for patients with oropharyngeal cancer: a case control study and an additional HPV-status subgroup analysis
por: Gan, XiaoChuan, et al.
Publicado: (2023) -
Precision therapy for RET-altered cancers with RET inhibitors
por: Thein, Kyaw Z., et al.
Publicado: (2021) -
RET kinase alterations in targeted cancer therapy
por: Liu, Xuan, et al.
Publicado: (2020) -
Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant Cancers
por: Adashek, Jacob J., et al.
Publicado: (2021)